JPD Capital has launched a cannabis focused fund to harness the growth of the global medicinal cannabis market.
The fund has said they will invest in companies anywhere in the ‘seed-to-sale’ supply chain, from cultivators all the way through to CBD brands.
JPD Capital is domiciled Guernsey with operations based in London.
The cannabis investment vehicle has a minimum investment of £25,000 and is restricted to sophisticated, high net worth and professional investors.
Jon-Paul Doran, founder of JPD Capital, said: “I am delighted to be launching our medicinal cannabis fund in the UK. The success of our pharmaceutical arm Eco Equity over the past 18 months shows there is appetite for investment in the industry.
“The cannabis market is the fastest-growing market of 2019, proving its unstoppable growth and obvious attraction for investors.”
JDP Capital Fund
JDP Capital was first unveiled at the Cannabis Investor Forum 2019 held in London.
When speaking at the Cannabis Investor Forum Jon-Paul Doran said “We have identified other regions where I believe we can execute our model.”
Having made that statement in October, JPD Capital followed through with investments in Antigua to add to their initial operations in Zimbabwe facilitated by their pharmaceutical Eco Equity.
As well as cultivation, there are plans for the launch for dispencaries throughout the Caribbean.
Eco Equity have recently announced an update to their project in Zimbabwe which is expect to yield its first crop in mid 2020.
The launch of JPD Capital comes shortly after the first medicinal cannabis UCITS ETF was launched by HANetf.
HANetf takes an ultra-low cost approach to the medicinal cannabis sector with their Medical Cannabis and Wellness UCITS ETF.
The top holdings of the ETF include Corbus Pharmaceuticals Holdings, GW Pharmaceuticals, Scotts Miracle-Gro and Charlotte’s Web.
The ETF is listed in both the UK and Germany and has a total expense ratio of 0.8%.